Argenx VYVGART Hits $5B Revenue as Price Targets Range €900–€1,227
Barclays kept its Buy rating with a €900 target, while Baird raised its to $867 following a strong Q4 revenue report. Stifel cut its target from $1,248 to $1,227 as VYVGART now generates over $5B annually, implying consensus $5.7B forecasts could be conservative.
1. Analyst Ratings and Targets
Barclays maintained Buy with a €900 price target; Baird raised to $867 and reaffirmed Neutral; Stifel cut its target from $1,248 to $1,227 while maintaining a Buy rating.
2. Q4 Financial Impact
Argenx's fourth-quarter report showed stronger-than-expected revenue growth alongside higher operating expenses, prompting Baird to revise its financial model.
3. VYVGART Franchise Performance
VYVGART now generates over $5 billion in annual sales, and management’s steady outlook suggests the consensus $5.7 billion forecast may be conservative.